Bessemer Group Inc. Decreases Holdings in Analogic Co. (ALOG)

Bessemer Group Inc. reduced its position in shares of Analogic Co. (NASDAQ:ALOG) by 24.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 16,800 shares of the medical research company’s stock after selling 5,400 shares during the quarter. Bessemer Group Inc.’s holdings in Analogic were worth $1,407,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Voya Investment Management LLC boosted its stake in Analogic by 9.5% during the 2nd quarter. Voya Investment Management LLC now owns 6,087 shares of the medical research company’s stock valued at $442,000 after purchasing an additional 529 shares in the last quarter. Flinton Capital Management LLC boosted its stake in Analogic by 100.0% during the 2nd quarter. Flinton Capital Management LLC now owns 1,768 shares of the medical research company’s stock valued at $129,000 after purchasing an additional 884 shares in the last quarter. Parametric Portfolio Associates LLC boosted its stake in Analogic by 2.7% during the 2nd quarter. Parametric Portfolio Associates LLC now owns 34,110 shares of the medical research company’s stock valued at $2,478,000 after purchasing an additional 912 shares in the last quarter. California Public Employees Retirement System boosted its stake in Analogic by 3.4% during the 2nd quarter. California Public Employees Retirement System now owns 42,900 shares of the medical research company’s stock valued at $3,117,000 after purchasing an additional 1,400 shares in the last quarter. Finally, AHL Partners LLP boosted its stake in Analogic by 13.9% during the 2nd quarter. AHL Partners LLP now owns 13,091 shares of the medical research company’s stock valued at $951,000 after purchasing an additional 1,594 shares in the last quarter. 98.15% of the stock is owned by hedge funds and other institutional investors.

ALOG has been the subject of a number of research reports. Zacks Investment Research raised Analogic from a “hold” rating to a “buy” rating and set a $93.00 price target for the company in a research note on Tuesday, October 10th. BidaskClub lowered Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Finally, Jefferies Group reiterated a “hold” rating and set a $80.00 price objective on shares of Analogic in a research report on Friday, December 8th.

Shares of Analogic Co. (ALOG) opened at $79.75 on Wednesday. Analogic Co. has a 52-week low of $66.00 and a 52-week high of $89.50. The company has a market capitalization of $1,055.58, a price-to-earnings ratio of -13.94, a PEG ratio of 4.22 and a beta of 0.82.

Analogic (NASDAQ:ALOG) last announced its quarterly earnings data on Wednesday, December 6th. The medical research company reported $0.75 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.32. Analogic had a positive return on equity of 5.09% and a negative net margin of 15.06%. The company had revenue of $106.90 million during the quarter, compared to the consensus estimate of $100.55 million. During the same quarter in the prior year, the firm earned $0.43 EPS. The company’s quarterly revenue was down 11.7% compared to the same quarter last year. research analysts expect that Analogic Co. will post 2.86 earnings per share for the current year.

WARNING: “Bessemer Group Inc. Decreases Holdings in Analogic Co. (ALOG)” was originally published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.com-unik.info/2018/02/07/bessemer-group-inc-decreases-holdings-in-analogic-co-alog.html.

Analogic Profile

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Want to see what other hedge funds are holding ALOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Analogic Co. (NASDAQ:ALOG).

Institutional Ownership by Quarter for Analogic (NASDAQ:ALOG)

Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit